Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Insmed (INSM) Cost of Revenue (2018 - 2026)

Insmed's Cost of Revenue history spans 9 years, with the latest figure at $47.4 million for Q1 2026.

  • Quarterly Cost of Revenue rose 122.86% to $47.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $149.1 million through Mar 2026, up 66.45% year-over-year, with the annual reading at $122.9 million for FY2025, 43.38% up from the prior year.
  • Cost of Revenue came in at $47.4 million for Q1 2026, up from $44.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $47.4 million in Q1 2026 to a low of $12.2 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $18.4 million (2023), against an average of $22.2 million.
  • Year-over-year, Cost of Revenue decreased 1.65% in 2022 and then soared 122.86% in 2026.
  • Insmed's Cost of Revenue stood at $13.1 million in 2022, then soared by 41.12% to $18.4 million in 2023, then soared by 41.79% to $26.2 million in 2024, then skyrocketed by 69.09% to $44.2 million in 2025, then grew by 7.24% to $47.4 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Cost of Revenue are $47.4 million (Q1 2026), $44.2 million (Q4 2025), and $29.4 million (Q3 2025).